Cover Image
close this bookImmunization Policy, 1996 (WHO - OMS, 1996, 63 p.)
View the document(introduction...)
View the document1. Introduction
View the document2. Vaccines used in the EPI
View the document3. Basic immunization schedules and strategies
View the document4. The expected effect of immunization on disease epidemiology
View the document5. Additional schedules and strategies
View the document6. HIV infection and immunization
View the document7. Reactions following immunization
View the document8. Other vaccines that can be used as a part of EPI
View the document9. References

9. References

ACIP (Immunization Practices Advisory Committee): Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Morb Mort Wkly Rep 1991a, 40: RR 13.

ACIP (Immunization Practices Advisory Committee): Diphtheria, Tetanus, and Pertussis: Recommendations for vaccine use and other preventive measures. Morb Mort Wkly Rep 1991b, 40: no. RR 10.

ACIP (Immunization Practices Advisory Committee): Pertussis vaccination: Acellular pertussis vaccine for reinforcing and booster use - Supplementary ACIP Statement. Morb Mort Wkly Rep 1992, 41: no. RR 1.

ACIP (Immunization Practices Advisory Committee): Inactivated Japanese encephalitis virus vaccine. Recommendations of the ACIP. Morb Mort Wkly Rep 1993a, 42: no. RR 1.

ACIP (Immunization Practices Advisory Committee): Recommendations for use of Haemophilus b conjugate vaccines and a combined diphtheria, tetanus, pertussis, and Haemophilus b vaccine. Morb Mort Wkly Rep 1993b, 42: RR 13.

ACIP (Immunization Practices Advisory Committee): General recommendations on immunization. Morb Mort Wkly Rep 1994, 43: No RR 1.

Alonso P.L., Smith T., Schellenberg J.R. et al: Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet 1944, 344: 1175 - 1181.

American Academy of Pediatrics: Report of the Committee on Infectious Diseases (Red Book), Twenty-second edition, 1991.

Anonymous: Measles elimination by the year 2000. EPI Newsletter. Expanded Program on Immunization in the Americas, 1994, 16: 1-2.

Benenson A.S. (Editor) Control of Communicable Diseases in Man. Report of the American Public Health Association. Fifteenth Edition, 1990.

Bernbaum J.C., Daft A., Anolik R. et al.: Response of preterm infants to diphtheria-tetanus- pertussis immunizations. J Pediatr 1985, 107: 184 - 188.

Bernier R.H., Frank J.A., Nolan T.F.: Abscesses complicating DTP vaccination. Amer J Dis Child 1981, 135: 826 - 828.

Bhandari B., Khurana R., Mandowara S.L.: Management of post-BCG lymphadenitis. Indian J Pediatr 1980, 47: 367 -370.

Blanche S., Le Deist F., Fischer A. et al.: Longitudal study of 18 children with perinatal LAV/HTL III infection: Attempt at prognostic evaluation. J Pediatr 1986, 109: 965 - 970.

Blennow M., Olin P., Granstrom M., Bernier R.H.: Protective efficacy of a whole cell pertussis vaccine. Brit Med J 1988, 296: 1570 -1572.

Booy R., Aitken S.J.M., Taylor S. et al. Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3 and 4 months versus 3, 5 and 9 months of age. Lancet 1992, 339: 507-510.

Borkovsky W., Rigaud M., Krasinski K. et al.: Cell-mediated and humoral immune responses in children infected with human immunodeficiency virus during the first four years of life. J Pediatr 1992, 120: 371 - 375.

Bytchenko B.: Immunization calendars in developed countries. In: Working Group on Immunization of Tourist and Other Travellers, Venice, 11-13 November 1990. WHO Document 1990 ICP/EPI 025/21 7957s.

Camargos P.A.M., Guimaraes M.D., Antunes C.M.F.: Risk assessment for acquiring meningitis tuberculosis among children not vaccinated with BCG: A case-control study. Int J Epidemiol 1988, 17: 193 - 197.

Cellesi C., Zanchi A., Michelangeli C. et al.: Immunity to diphtheria in a sample of adult population from central Italy. Vaccine 1989, 7: 417 - 420.

Centers for Disease Control (CDC): Disseminated Mycobacterium bovis infection from BCG vaccination of a patient with acquired immunodeficiency syndrome. Morb Mort Wkly Rep 1985, 34: 227 - 228.

Centers for Disease Control (CDC): BCG vaccination and pediatric HIV infection - Rwanda, 1988 - 1990. Wkly Epidemiol Rec 1992, 67: 129 - 132.

Chen R.T., Weierbach R., Bisoffi Z. et al.: A “post-honeymoon period” measles outbreak in Muyinga province, Burundi. Int J Epidemiol 1994, 23: 185-193.

Cherry J.D.: Pertussis: the trials and tribulations of old and new pertussis vaccines. Vaccine 1992, 10: 1033 - 1038.

Cherry J.D.: Acellular pertussis vaccines - a solution to the pertussis problem. J Infect Dis 1993, 168: 21-24.

Clemens J.D., Sack D.A., Harris J.R. et al.: Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet 1990, 335: 270 - 273.

Clements C.J., von Reyn C.F., Mann J.M.: HIV infection and routine childhood immunization: a review. Bull WHO 1987, 65: 905 - 911.

Cody C.L., Baraff L.J., Cherry J.D., et al.: The nature and rate of adverse reactions associated with DTP and DT immunization in infants and children. Pediatrics 1981, 68: 650 -660.

Collier L.H., Polakoff S., Mortimer J.: Reactions and antibody response to reinforcing doses of adsorbed and plain tetanus vaccines. Lancet 1979, 1: 1364 -1368.

Comstock G.W. Livesay V.T., Woolpert S.F.: Evaluation of BCG vaccination among Puerto Rican children. Am J Public Health 1974, 64: 283 -291.

Conway S.P., James J.R., Smithells R.W. et al.: Immunisation of the preterm baby. Lancet 1987, 2: 1326.

Conway S., James J., Balfour A., et al.: Immunisation of the preterm baby. J Infect 1993, 27: 143 - 150.

Crossley K., Irvine P., Warren J.B. et al.: Tetanus and diphtheria immunity in urban Minnesota adults. JAMA 1979, 242: 2298-2300.

Cutts F.T., Mandala K., St Louis M. et al.: Immunogenicity of high titer Edmonston-Zagreb measles vaccine in HIV-infected children in Kinshasa, Zaire. J Infect Dis 1993, 167: 1418 - 1421.

Cutts F.T., Smith P.G.: Vaccination and World Health. Wiley, London 1994.

Davis M.W., Walker P.D.: Antibody response to pig bel vaccine in infants less than one year old. Papua New Guinea J 1982, 25: 235 - 238.

Doming M.S., Jaiteh K.O., Otten M.W. et al.: Epidemic poliomyelitis in The Gambia following the control of poliomyelitis as an epidemic disease. II. Clinical efficacy of trivalent oral polio vaccine. Amer J Epidemiol 1992, 135: 393 -408.

Department of Health and Social Security, Welsh Office, Scottish Home and Health Department: Immunisation against Infectious Diseases. HMSO 1990

Deseda-Tous J., Cherry J.D., Spencer M.J. et al. Measles revaccination. Persistence and degree of antibody titer by type of immune response. Am J Dis Child 1978, 132: 287 - 290.

De-Xiang D., Xi-min H., Wan-Jun L. et al.: Immunization of neonates with trivalent oral poliomyelitis vaccine (Sabin). Bull WHO 1986, 64: 853 - 860.

Diaz-Ortega J-L., Forsey T., Clements C.J., Milstien J.: The relationship between dose and response of standard measles vaccines. Biologicals 1994, 22: 35-44.

Dudgeon J.A., Cutting W.A.M.. (Eds): Immunization. Principles and Practice. Chapman and Hall Medical 1991.

Editorial. Typhoid vaccination: weighing the options. Lancet 1992, 340: 341-342.

Edwards K.M.: Acellular pertussis vaccines-a solution to the pertussis problem? J Infect Dis 1993, 168: 15-20.

Embree J.E., Datta P., Stackiw W. et al.: Increased risk of early measles in infants of Human Immunodeficiency Virus type 1 - seropositive mothers. J Infect Dis 1992, 165: 262 - 267.

Expanded Programme on Immunization: Intervals between successive doses of killed vaccines. The persistence of immunological memory and implication for the EPI. Wkly Epidemiol Rec 1979, 54: 388 - 389.

Expanded Programme on Immunization: Immunization Policy. WHO Document WHO/EPI/GEN/86/7 Rev 1, 1986.

Expanded Programme on Immunization: Global Advisory Group. Wkly Epidemiol Rec 1987a, 62:5-9.

Expanded Programme on Immunization: Joint WHO/UNICEF statement on immunization and AIDS. Wkly Epidemiol Rec 1987b, 62: 53-54.

Expanded Programme on Immunization: Contraindications for vaccines used in EPI. Wkly Epidemiol Rec 1988, 63: 279 - 281.

Expanded Programme on Immunization: Measles outbreak, Hungary. Wkly Epidemiol Rec 1989, 64: 137 - 138.

Expanded Programme on Immunization: Global Advisory Group. Part II. Wkly Epidemiol Rec 1991a, 66: 9 - 12.

Expanded Programme on Immunization: Training for mid level managers. Identify missed opportunities. WHO Document WHO/EPI/MLM/91.7, 1991b.

Expanded Programme on Immunization. Responding to a suspected polio outbreak: case investigation, surveillance and control. A manager’s checklist. WHO Document WHO/EPI/POL/91.3, 1991c.

Expanded Programme on Immunization. Rubella and congenital rubella syndrome in developing countries. WHO Document EPI/GAG/91/WP.15, 1991d.

Expanded Programme on Immunization: EPI for 1990s. WHO Document WHO/EPI/GEN/92.2, 1992a.

Expanded Programme on Immunization: Global Poliomyelitis Eradication by the year 2000. WHO Document WHO/EPI/POLIO/92.2, 1992b.

Expanded Programme on Immunization. Global Advisory Group - Part I. Wkly Epidemiol Rec 1992c, 67: 11-15.

Expanded Programme on Immunization: The resurgence of deadly yellow fever. EPI Update, 1992d, 21 March.

Expanded Programme on Immunization: Measles outbreak 1989 - 1990, Poland. Wkly Epidemiol Rec 1992e, 67: 50 - 54.

Expanded Programme on Immunization: Global Advisory Group. Part III. Wkly Epidemiol Rec 1992f, 67: 27 - 30

Expanded Programme on Immunization: Global Advisory Group. Revised Plan of Action for Neonatal Tetanus Elimination. EPI Document: EPI/GAG/93/WP.12, 1993a.

Expanded Programme on Immunization: Global Advisory Group. Revised Plan of Action for Global Measles Control. EPI Document: EPI/GAG/93/WP.10, 1993b.

Expanded Programme on Immunization: The Immunological Basis for Immunization. WHO Documents WHO/EPI/GEN/93.12 - 93.19, Module 1: General Immunology (A. Galazka); Module 2: Diphtheria (A. Galazka); Module 3: Tetanus (A. Galazka); Module 4: Pertussis (A. Galazka), Module 5: Tuberculosis (J. Milstien); Module 6: Poliomyelitis (S. Robertson); Module 7: Measles (F. Cutts); Module 8: Yellow fever (S. Robertson), Geneva 1993c.

Expanded Programme on Immunization: Global Advisory Group - Part I. Wkly Epidemiol Rec 1993d, 68: 1-6.

Expanded Programme on Immunization: Global Advisory Group. Part II. Wkly Epidemiol Rec 1993e, 68: 11 - 16.

Expanded Programme on Immunization: Surveillance of adverse events following immunization. Field guide for managers of immunization programmes. WHO Document WHO/EPI/TRAM/93.2, 1993f.

Expanded Programme on Immunization: Framework for evaluating a vaccine for the EPI. WHO Document WHO/EPI/GEN/93.5; 1993g.

Expanded Programme on Immunization: Outbreak of diphtheria, Update. Russian Federation. Wkly Epidemiol Rec 1993h, 68: 134 - 138.

Expanded Programme on Immunization: Diphtheria epidemic. Ukraine. Wkly Epidemiol Rec 1994a. 69: 253 - 258.

Expanded Programme on Immunization: Japanese encephalitis. Inactivated Japanese encephalitis virus vaccine. Wkly Epidemiol Rec 1994b, 69: 113 - 120.

Expanded Programme on Immunization: Accelerated measles strategies. Wkly Epidemiol Rec 1994c, 69: 229 - 234.

Expanded Programme on Immunization: Immunization of adults against diphtheria. Wkly Epidemiol Rec 1995, 70: 56 - 59.

Farizo K.M., Strebel P.M., Chen R.T. et al. Fatal respiratory disease due to Corynebacterium diphtheriae: case report and review of guidelines for management, investigation and control. Clin Infect Dis 1993; 16: 59-68.

Feldman W.E.: Current status of pediatric vaccines. Postgrad Med 1991, 90: 135 - 140

Fine P.E.M., Clarkson J.A.: Reflections on the efficacy of pertussis vaccines. Rev Infect Dis 1987, 9: 866 - 883.

Fine P.E.M.: The BCG story. Rev Infect Dis 1989; 11, supplement 2: S353 - 359.

Fine P.E.M., Rodriques L.C.: Modern vaccines. Mycobacterial diseases. Lancet 1990, 335: 1016 - 1020.

Galazka A.M., Lauer B.A., Henderson R.H., Keja J.: Indications and contraindications for vaccines used in the Expanded Programme on Immunization. Bull WHO 1984, 62: 357 - 366.

Galazka A.: Rubella in Europe. Epidemiol Infect 1991, 107: 43 - 54.

Galazka A.: Control of pertussis in the world. Wrld Hlth Statist Quart 1992, 45: 238 - 247.

Galazka A.M., Robertson S.E., Oblapenko G.P.: Resurgence of diphtheria. Eur J Epidemiol, 1995a, 11: 95 - 105.

Galazka A.M., Robertson S.E.: Diphtheria - changing patterns in the developing world and the industrialized world. Eur J Epidemiol, 1995b, 11: 107 - 117.

Geseman M., Scheiemann N., Brockmeyer N. et al. Clinical evaluation of a recombinant hepatitis B vaccine in HIV-infected vs uninfected persons. In: Zuckerman AJ, ed. Viral hepatitis and liver disease. New York: Alan R Liss; 1988: 1076-1078.

Global Programme on AIDS and Expanded Programme on Immunization: Joint WHO/UNICEF statement on early immunization for HIV-infected children. Wkly Epidemiol Rec 1989, 64: 48 - 49.

Global Programme for Vaccines: Role of mass campaigns in global measles control. Lancet 1994, 344: 174 - 175.

Groot H., Riberiro R.B.: Neutralizing and haemagglutination-inhibiting antibodies to yellow fever 17 years after vaccination with 17D vaccine. Bull WHO 1962, 27: 669 - 707.

Hall AJ.: Hepatitis B vaccination: protection for how long and against what? Brit Med J 1993, 307: 276-277.

Hall AJ.: Control of hepatitis B by childhood vaccination. Rev Med Microbiol 1994,5: 123 - 130.

Halsey N.A., Boulos R., Mode F. et al.: Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibody, malnutrition, and concurrent illnesses. New Engl J Med 1985, 313: 544 - 549.

Halsey N., Galazka A.: The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age. Bull WHO 1985, 63: 1151-1169.

Hanley S.P., Gumb J., Macfarlane J.T.: Comparison of erythromycin and isoniazid in treatment of adverse reactions to BCG vaccination. Brit Med J 1985, 290: 970.

Health and Welfare, Canada: A guide to immunisation for Canadians, Second Edition, 1984.

Hersh B.S., Markowitz L.E., Maes E.F. et al.: The geographic distribution of measles in the United States, 1980 through 1989. JAMA 1992, 267: 1936 - 1941.

Hospedales C.J. Update on elimination of measles in the Caribbean. West Indian Med J 1992, 41: 43-44.

Houde C., Dery P.: Mycobacterium bovis sepsis in an infant with human immunodeficiency virus infection. Pediatr Infect Dis J 1988, 7: 810 - 812.

Howson C.P., Fineberg H.V.: Adverse events following pertussis and rubella vaccines. Summary of a report of the Institute of Medicine. JAMA 1992a, 267: 392 - 396.

Howson C.P., Fineberg H.V.: The ricochet of magic bullets: Summary of the Institute of Medicine Report, Adverse events of pertussis and rubella vaccines. Pediatrics 1992b, 89: 318 - 324.

Hull H.F., Ward N.A., Hull B.P. et al.: Paralytic poliomyelitis: seasoned strategies, disappearing disease. Lancet 1994, 343: 1331 - 1337.

Hutchins S.S., Jansen H.A., Robertson S.E. et al.: Studies of missed opportunities for immunization in developing and industralized countries. Bull WHO 1993, 71: 549 - 560.

Igarashi A.: Epidemiology and control of Japanese encephalitis. World Health Statist Quart 1992, 45: 299 - 305.

Ivanoff B., Levine M.M., Lambert P.H.: Vaccination against typhoid fever: present status. Bull. WHO 1994, 72: 957 - 971.

Jenkinson D.: Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study. Br Med J 1988, 296: 612 - 614.

Jin B.W., Hong Y.P., Kim S.J.: A contact study to evaluate the BCG vaccination programme in Seoul. Tubercle 1989, 70: 241 - 249.

Jones A.E., Johns A., Magrath D.I., et al.: Durability of immunity to diphtheria, tetanus and poliomyelitis after a three dose immunization schedule completed in the First eight months of life. Vaccine 1989, 7: 300 - 302.

Jones E.E., Kim-Farley R.J., Algunaid M. et al.: Diphtheria: a possible foodborne outbreak in Hodeida, Yemen Arab Republic. Bull WHO 1985, 63: 287 - 293.

Kambarami R.A, Nathoo K.J., Nkruma F.F., Pirie D.J.: Measles epidemic in spite of high measles immunization coverage rates in Harare, Zimbabwe. Bull WHO 1991,69: 213 - 219.

Kaplan L.J., Daum R.S., Smaron M., McCarthy C.A.: Severe measles in immunocompromised patients. JAMA 1992, 267: 1237 - 1241.

Karanth S., Coninx R., Dickson C., Murrell T.G.C.: Enteritis necroticans (Pig Bel) on Thai/Kampuchean border? Lancet 1986, 1: 1437.

Kim-Farley R.J., Rutheford G., Lichfield P. et al.: Outbreak of paralytic poliomyelitis, Taiwan. Lancet 1984, 2: 1322 - 1324.

Kim-Farley R.J., Soewarso T.I., Karyadi A., Adhyatma M.: Assessing the impact of the Expanded Programme on Immunization: the example of Indonesia. Bull WHO 1987, 63: 203 - 206.

King G.E., Hadler S.C.: Simultaneous administration of childhood vaccines: an important public health policy that is safe and efficacious. Pediatr Infect Dis J 1994,13: 394 - 407.

Krasinski K., Borkovsky W.: Measles and measles immunity in children infected with Human Immunodeficiency Virus. JAMA 1989, 261: 2512 - 2516.

Kubit S., Czajka S., Olakowska T., Piasecki Z.: Evaluation of the effectiveness of BCG vaccinations. Pediatr. Pol. 1983, 47: 777 - 781.

Lallemant-LeCoeur S., Lallemant M., Cheynier D. et al.: Bacillus Calmette-Guerin immunization in infants born to HIV-1 seropositive mothers. AIDS 1991, 5: 195-199.

Lawrence G., Shann F., Freestone D.S., Walker P.D.: Prevention of necrotising enteritis in Papua New Guinea by active immunisation. Lancet 1979, 1: 227 - 230.

Lepage P., Dabis F., Msellati P. et al.: Safety of immunogenicity of high-dose Edmonston-Zagreb measles vaccine in children with HIV-1 infection. A cohort study in Kigali, Rwanda. Amer J Dis Child 1992, 146: 550 - 555.

Levine M.M.: Modern vaccines. Enteric infections. Lancet 1990, 1: 958 - 961.

Levine M.M, Hone D., Tacket C.O.: Update on typhoid vaccines. Sem Ped Infect Dis 1991, 2: 159 - 162.

Levine M.M., Kaper J.B.: Live oral vaccines against cholera: an update. Vaccine 1993, 11:207-212.

Loutan L., Paillard S.: The epidemiology of measles in a nomadic community. Bull WHO 1992, 70: 741 - 744.

Lugosi L.: Analysis of the efficacy of mass BCG vaccination from 1959 to 1983 in tuberculosis control in Hungary. Bull Intern Union Tuberc 1987, 16: 15 - 34.

Markowitz L.E, Albrecht P., Orenstein W.A., et al.: Persistence of measles antibody after revaccination. J Infect Dis 1992, 166: 205 - 208.

Mathias R., Meekison J., Arcan T., Schechter M.: The role of secondary vaccine failures in measles outbreaks. Am J Public Health 1989, 79: 475 - 478.

McLaughlin M., Thomas P., Onorato I. et al.: Use of live virus vaccines in HIV-infected children: a retrospective survey. Pediatrics 1988, 82: 229 - 233.

Meegan J.M.: Yellow fever vaccine. WHO Document WHO/EPI/GEN/91.6, 1991.

Micelli I., de Kantor I.N., Colaiacovo D. et al.: Evaluation of the effectiveness of BCG vaccination using the case-control method in Buenos Aires, Argentina. Intern J Epidemiol 1988, 17: 629 - 634.

Milstien J.B, Gibson J.J.: Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety. Bull WHO 1990, 68: 93 - 108.

Modern vaccines. Current Practices and New Approaches. Lancet review. Editorial Adviser: E.R. Moxon. E. Arnold 1990.

Moore P.S. et al.: Surveillance and control of meningococcal meningitis epidemics in refugee populations. Bull WHO, 1990, 68: 587 - 596.

Moore P.S. et al.: Detection of meningitis epidemics in Africa: A population-based analysis. Intern J Epidemiol 1992, 21: 155 - 162.

Muller A.S., Leeuwenburg J., Voorhoeve A.M.: Pertussis in a rural area of Kenya: epidemiology and results of a vaccine trial. Bull WHO 1984, 62: 899 - 908

Murrel T.G.C.: Pigbel: Clostridium perfringens type C enterotoxemia. Sem Infect Dis 1982, 4: 37 - 41.

National Health and Medical Research Council, Australia: Immunisation Procedures, IV Edition, 1991.

Ninane J., Grymonprez A., Burtonboy G. et al.: Disseminated BCG in HIV infection. Arch Dis Child 1988, 63: 1268 - 1269.

Nossal G.J.V.: in Protecting the World’s Children: Vaccines and Immunization within Primary Health Care, Bellagio Conference, March 13 - 15, 1984: 105-110

Novotny T., Jennings C.E., Doran M. et al.: Measles outbreaks in religious groups exempt from immunization laws. Public Health Rep 1988, 103: 49 - 54.

Nunn P.: HIV associated pulmonary tuberculosis. Africa Health 1991, November: 10-11.

Nunn P. et al.: Impact of Human Immunodeficiency Virus on transmission and severity of tuberculosis. Trans Roy Soc Trop Med Hyg 1990, 88, Suppl. 1: 9.

Onorato I.M., Markowitz L.E., Oxtoby M.J.: Childhood immunization, vaccine-preventable diseases and infection with human immunodeficiency virus. Pediatr Infect Dis J 1988, 6: 588 - 595.

Onorato I.M., Markowitz L.E.: Immunizations, vaccine-preventable diseases, and HIV infection. In: AIDS and other manifestations of HIV infections. Second Edition. Edited by G.P. Wormser. Raven Press, N. York 1992: 671 - 681.

Otten M.W., Doming M.S., Jaiteh K.O. et al.: Epidemic poliomyelitis in The Gambia following the control of poliomyelitis as an endemic disease. I. Descriptive findings. Amer J Epidemiol 1992, 135: 381 - 392.

Oxtoby M.S. Mvula M., Ryder R. et al.: Measles and measles immunity in African children with HIV. Twenty-eighth Interscience Conference on Antimicrobial Agents and Chemotherapy, Los Angeles, Oct 23-26, 1988.

Pan American Health Organization (PAHO): Polio incidence rises in Brazil’s northeast. EPI Newsletter 1986, 8: 429 - 433.

Pan American Health Organization: Measles elimination in the Americas. Bull PAHO 1992, 26: 271 - 275.

Pappenheimer A.M., Murphy J.R.: Studies on the molecular epidemiology of diphtheria. Lancet 1983, 2: 923 - 926.

Pediatrics. Current status of Haemophilus influenzae type b vaccines. Pediatrics 1990, 85: supplement.

Pichichero M.E. et al. Acellular pertussis vaccine; immunogenicity and safety of an acellular pertussis vs. a whole cell pertussis vaccine combined with diphtheria and tetanus toxoids as a booster in 18 to 24 month old children. Pediatr Infect Dis J 1987, 6: 352 - 363.

Plotkin S.A., Mortimer E.A. (Editors). Vaccines. Philadelphia, W.B. Sanders 1994

Poland J.D., Calisher C.H., Monath T.P.: Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine. Bull WHO 1981, 59: 895 - 900.

Rao Bhau L.N.: Immunization against Japanese encephalitis. Indian J Med Sci 1992, 46: 309-313.

Ramsay M.E.B., Corbel M.J., Redhead K. et al.: Persistence of antibody after accelerated immunisation with diphtheria/tetanus/pertussis vaccine. Brit Med J 1991, 302: 1489 - 1491.

Research Committee of the British Thoracic Association: Effectiveness of BCG vaccination in Great Britain in 1978. Brit J Dis Chest 1980, 74: 215 - 227.

Reyes M.A., Franky de Borrero M., Roa J. et al.: Measles vaccine failure after documented seroconversion. Pediatr Infect Dis J 1987, 6: 848 - 851.

Reynes J., Perez C., Lamaury I. et al.: Bacille Calmette-Guerin adenitis 30 years after imunization in patient with AIDS. J Infect Dis 1989, 160: 727.

Rodrigues L.C., Diwan V.D., Wheeler J.G.: Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol 1993, 22: 1154 - 1158.

Romanus V., Fasth A., Tordai P., Whilom B.E.: Adverse reactions in healthy and immunocompromised children under six years of age vaccinated with the Danish BCG vaccine, strain Copenhagen 1331: implications for the vaccination policy in Sweden. Acta Paediatr 1993, 82: 1043 - 1052.

Roper J., Day S.: Uptake in immunization in low birthweight infants. Arch Dis Child J 1988, 63: 518-521.

Rosenthal S., Clements CJ.: Two-dose measles vaccination schedules. Bull WHO 1993, 71: 421 - 428.

Rosenzweig E.C., Babione R.W., Wisseman C.L. Jr.: Immunological studies with group B arthopod-borne viruses. IV. Persistence of yellow fever antibodies following vaccination with 17D strain yellow fever vaccine. Am J Trop Med Hyg 1963, 12: 230 - 235.

Rumke H.C., Schlumberger M., Floury B. et al.: Serological evaluation of a simplified immunization schedule using quadruple DPT-polio vaccine in Burkina Faso. Vaccine 1993, 11: 1113 - 1118.

Ryder R.W., Oxtoby M.J., Mvula M. et al.: Safety and immunogenicity of bacille Calmette- Guerin, diphtheria-tetanus-pertussis, and oral polio vaccines in newborn children in Zaire infected with human immunodeficiency virus type 1. J Pediatr 1993, 122: 697 - 702.

Sangpetchsong V., Impat A., Dhiensiri K., Podhipak A.: Effect of passive immunity to tetanus in DTP vaccinated infants. Southeast Asian J Trop Med Publ Hlth 1985, 16: 117 - 123.

Schoub B.D., Johnson S., McAnerney J.M. et al.: Poliomyelitis outbreak in Natal/KwaZulu, South Africa 1987 - 1988. 2. Immunity aspects. Trans Roy Soc Trop Med Hyg 1992, 86: 83 - 85.

Schulzer M., Fitzgerald J.M., Enarson D.A., Grzybowski S.: An estimate of the future size of the tuberculosis problem in sub-Saharan Africa resulting from HIV infection. Tubercle Lung Dis 1992, 73: 52 - 58.

Sempertegui F., Estrella B., Moscoso J. et al.: Safety, immunogenicity and protective effect of the SPf66 malaria synthetic vaccine against Plasmodium falciparum infection in a randomized double-blind placebo-controlled field trial in an endemic area of Ecuador. Vaccine 1994, 12: 337 - 342.

Shann F., Lawrence G., Jun-Di P.: Enteritis necroticans in China. Lancet 1979, 1: 1083.

Shann F.: Modern Vaccines. Pneumococcus and influenza. Lancet 1990, 1: 898-901.

Simonsen O., Badsberg J.H., Kjeldsen K. et al. The fall-off in serum concentration of tetanus antitoxin after primary and booster vaccination. Acta Path Microbiol Immunol Scand 1986a, 94: 77 - 82.

Simonsen O., Klaerke M., Klaerke A. et al.: Revaccination of adults against diphtheria. II. Combined diphtheria and tetanus revaccination with different doses of diphtheria toxoid 20 years after primary vaccination. Acta path immunol scand. 1986b, Sect. C, 94: 219 - 225.

Simonsen O.: Vaccination against tetanus and diphtheria. Evaluation of immunity in the Danish population, guidelines for revaccination, and the methods for control of vaccination programs. Dan Med Bull 1989, 36: 24 - 47.

Sirinavin S., Chotpitayasunondh T., Suwanjutha S. et al.: Protective efficacy of neonatal Bacillus Calmette-Guerin vaccination against tuberculosis. Pediatr Infect Dis J 1991, 10: 359 - 365.

Smolen P., Bland R., Heiligenstein E. et al.: Antibody response to oral polio vaccine in premature infants. J Pediatr 1983, 103: 917 - 919.

Special Programme on AIDS and Expanded Programme on Immunization: Consultation on human immunodeficiency virus (HIV) and routine childhood immunization. Wkly Epidemiol Rec 1987, 40: 297 - 299.

Stowman K.: Diphtheria rebounds. Epidemiol Inform Bull (United Nations Refugee and Relief Agency, Health Division) 1945, 1: 157 - 168.

Strebel P.M., Sutter R.W., Cochi S.L. et al.: Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis 1992, 14: 568 - 579.

Sutter R.W., Patriarca P.A., Brogan S. et al.: Outbreak of paralytic poliomyelitis in Oman: evidence of widespread transmission among fully vaccinated children. Lancet 1991, 338: 715 - 720.

Swartz T.A., Roumianzeff M., Peyron L. et al.: Use of a combined DPT-Polio vaccine in a reduced schedule. Develop biol Stand 1986, 65: 159 - 166.

tenDam H.G.: BCG vaccine and vaccination policy. EPI Global Advisory Group, 13th Meeting, 14 - 18 October 1990a, Cairo, Egypt. EPI Document EPI/GAG/90/WP.8

tenDam H.G.: BCG vaccination and HIV infection. EPI Research and Development Group Meeting, 10-11 October 1990b, Cairo, Egypt. EPI Document EPI/RD/90/WP.6 Oct.

Vilmer E., Fischer A., Griscelli C. et al.: Possible transmission of a human lymphotropic retrovirus (LAV) from mothers to infants with AIDS. Lancet 1984,2: 229 - 230.

Wasz-Hockert O., Genz H., Landman H., Ocklitz H.: The effect of systematic BCG vaccination of newborns on the incidence of postprimary tuberculosis meningitis in childhood. Bull Intern Union Tuber Lung Dis 1988, 63: 49 - 51.

Weckx L.Y., Schmidt B.J., Herrman A.A. et al.: Early poliomyelitis immunization of neonates with trivalent oral polio vaccine. Bull WHO 1992, 70: 85 - 91.

World Health Organization: Tuberculosis control and research strategies for the 1990s: Memorandum from a WHO meeting. Bull WHO 1992, 70: 17-21.

World Health Organization: Research priorities for diarhoeal disease vaccines: Memorandum from a WHO meeting. Bull WHO 1991, 69: 667 - 676.

World Health Organization: Manual for the Management and Control of Diphtheria in the European Region. WHO Regional Office for Europe, WHO Document ICP/EPI 038 (B), Copenhagen, 1994.

World Health Organization: Malaria vaccine could be developed soon: global effort needed. Press release WHO/13, 13 February 1994.

World Summit Child. 1990. World Declaration on the Survival, Protection and Development of Children and Plan of Action for Implementing the World Declaration on the Survival, Protection and Development of Children in the 1990s. New York, United States.

Wright P.: Approaches to prevent acute bacterial meningitis in developing countries. Bull WHO 1989, 67: 479 - 486.